Genomic Analysis as the First Step toward Personalized Treatment in Renal Cell Carcinoma - Wikidata - awgldk - TriplyDB

Genomic Analysis as the First Step toward Personalized Treatment in Renal Cell Carcinoma

Genomic Analysis as the First Step toward Personalized Treatment in Renal Cell Carcinoma

http://www.wikidata.org/entity/Q33947929

about

Targeting glycogen metabolism in bladder cancer Targeting Strategies for Renal Cell Carcinoma: From Renal Cancer Cells to Renal Cancer Stem Cells DNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma.Three Dimensional Culture of Human Renal Cell Carcinoma Organoids Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy The Role of Hypoxia and Cancer Stem Cells in Renal Cell Carcinoma Pathogenesis.ARHGAP24 inhibits cell cycle progression, induces apoptosis and suppresses invasion in renal cell carcinoma.Loss of cadherin related family member 5 (CDHR5) expression in clear cell renal cell carcinoma is a prognostic marker of disease progression.The M6A methyltransferase METTL3: acting as a tumor suppressor in renal cell carcinoma.Impact of DNA and RNA Methylation on Radiobiology and Cancer Progression.

P2860

Q27025144-EC3EEDF9-3C77-47DD-93A3-7E315C802C61 Q28078154-5CF7E2AB-AADF-4582-9AEF-07DFD507F029 Q34694198-C6546923-FD0C-4F0F-A671-76F28A5490B0 Q35759222-30500E61-19F4-4D1A-8A99-D1A569D768D2 Q35947018-F9B18A29-701B-45AD-A160-0AFFCC2B7E71 Q36300487-1A3A0E99-4CBF-445F-ACA3-4832501AC4BE Q37588375-381F413B-7D21-4D25-8E6F-D63B23C34539 Q47115184-4B5998D5-7B9A-4A22-8C3D-A832BE70ADFF Q47314607-E05A9B4E-BD61-48EE-8AA6-8E78378584EC Q50033803-E5825622-1EA7-4D1A-B50E-FC0ED58B7D8F

P2860

Genomic Analysis as the First Step toward Personalized Treatment in Renal Cell Carcinoma

http://www.wikidata.org/entity/Q33947929

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Genomic Analysis as the First Step toward Personalized Treatment in Renal Cell Carcinoma

@ast

Genomic Analysis as the First Step toward Personalized Treatment in Renal Cell Carcinoma

@en

type

label

Genomic Analysis as the First Step toward Personalized Treatment in Renal Cell Carcinoma

@ast

Genomic Analysis as the First Step toward Personalized Treatment in Renal Cell Carcinoma

@en

prefLabel

Genomic Analysis as the First Step toward Personalized Treatment in Renal Cell Carcinoma

@ast

Genomic Analysis as the First Step toward Personalized Treatment in Renal Cell Carcinoma

@en

P1433

Q33947929-A6EBAD48-226C-4B65-8399-2A0F13CFC426

P1476

Q33947929-E71E85C3-EAC7-4654-A847-8D4DC7539E5D

P2093

Q33947929-8E63A97C-ACBC-4484-9201-062227109DAE

Q33947929-C8103465-7D34-40FF-94A9-E657A33CA7AE

P2860

Q33947929-00EC51EA-3C32-4B20-AF65-35D9AA213D42

Q33947929-030AD669-FBE1-431C-B397-516588B92F58

Q33947929-063ECBB9-E1C2-42FB-A494-CF67139EEE8B

Q33947929-09D38D5E-B63E-4DDB-BB56-D4ED5B374CF8

Q33947929-09FDFC8C-C3D2-4F2F-A10E-82AA00FA9DDF

Q33947929-0D17B7E9-C881-41AC-A9C1-4F7AC3748DC8

Q33947929-0E957ABD-7179-4588-B22E-EAC32577E844

Q33947929-10C9B836-1276-4461-A50C-9B2A1438C06A

Q33947929-119FA04C-4328-4950-BE0C-0AE95E215FD6

Q33947929-167A838E-E0F6-4BBC-BD38-FD9E0E0C5EDA

P304

Q33947929-996F5120-08CD-4B29-9C30-D26737F916B5

P31

Q33947929-08B704FB-5A87-4292-84C7-379C386126B0

P356

Q33947929-9082C93F-D858-4326-A86C-7E78CE64F1EE

P478

Q33947929-164A7F83-40F1-455F-B2D6-A9CA6A410420

P50

Q33947929-3CFD04B9-9523-4B06-A3CD-CDA6A4EDBCDD

P577

Q33947929-7F5BBF74-DF00-484C-93B5-481054E1F26D

P5875

Q33947929-D1CC78B8-A80A-4FF0-9B02-FE059C3B534F

P698

Q33947929-79C54642-3702-4F24-B04B-377319A08FF2

P932

Q33947929-4DE91D7E-967D-46E7-BF8E-4E32E02F60B4

P356

FONC.2014.00194

P1433

Frontiers in Oncology

P1476

Genomic Analysis as the First Step toward Personalized Treatment in Renal Cell Carcinoma

@en

P2093

Cezary Szczylik

http://www.w3.org/2001/XMLSchema#string

Zofia Felicja Bielecka

http://www.w3.org/2001/XMLSchema#string

P2860

Predictive biomarker discovery through the parallel integration of clinical trial and functional genomics datasets

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

Cancer genome landscapes

Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling

Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma

Mutational processes molding the genomes of 21 breast cancers

Gene expression profiling predicts survival in conventional renal cell carcinoma.

Molecular marker for predicting treatment response in advanced renal cell carcinoma: does the promise fulfill clinical need?

Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association

Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation.

P304

194

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FONC.2014.00194

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Anna M Czarnecka

P577

2014-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264205347

http://www.w3.org/2001/XMLSchema#string

P698

25120953

http://www.w3.org/2001/XMLSchema#string

P932

4110478

http://www.w3.org/2001/XMLSchema#string